Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Designed to Determine the Gastro-Retentive and Modified Release Properties of Memantine Hydrochloride (HCl) Prototype Capsule Formulations in Healthy Subjects

NCT03468543 is registered in ClinicalTrials.gov with Lyndra Inc. as lead sponsor.

NCT NCT03468543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03468543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Designed to Determine the Gastro-Retentive and Modified Release Properties of Memantine Hydrochloride (HCl) Prototype Capsule Formulations in Healthy Subjects
Lead sponsor
Lyndra Inc.
Phase
Phase 1
Overall status
Terminated
Start date
July 26, 2017
Completion date
September 18, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric retention, healthy